Nutritional Approaches to Mitigating Cognitive Decline and Maintaining Function in Alzheimer's Disease: Transgenic Mouse Models, Combinatorial Approaches, and Dietary Supplementation with Folate and S-Adenosyl Methionine

Diet and Nutrition in Dementia and Cognitive Decline

Volumn , Issue , 2015, Pages 837-845

  Shea, Thomas B ^a   Rogers, Eugene ^a   Remington, Ruth ^a,b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b FRAMINGHAM STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's Disease; Folate; Nutrition; Polymorphism; S Adenosyl Methionine; Transgenic Mouse Models

Indexed keywords

EID: 84922413745     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-407824-6.00077-X     Document Type: Chapter

References (50)

1. Shea TB, Rogers E, Remington R Nutrition and dementia: are we asking the right questions?. J Alzheimers Dis 2012, 30:27-33.
2. Wollen KA Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Alt Med Rev 2010, 15:226-244.
3. Mancuso C, Siciliano R, Barone E, Butterfield DA, Preziosi P Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. Expert Opin Investig Drugs 2011, 20:1243-1261.
4. Vellas B, Lauque S, Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashémi F, REAL.FR Group. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging 2005, 9:75-80.
5. Soto ME, Secher M, Gillette-Guyonnet S, van Kan GA, Andrieu S, Nourhashemi F, et al. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease. J Alzheimers Dis 2011, [Epub ahead of print].
6. Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J Am Diet Assoc 2007, 107:1322-1332.
7. de Sousa OL, Amaral TF Three-week nutritional supplementation effect on long-term nutritional status of patients with mild Alzheimer disease. Alzheimer Dis Assoc Disord 2011, [Epub ahead of print].
8. Morris MC Nutritional determinants of cognitive aging and dementia. Proc Nutr Soc 2011, 9:1-13.
9. Morris MC, Tangney CC A potential design flaw of randomized trials of vitamin supplements. JAMA 2011, 305:1348-1349.
10. Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007, 369:208-216.
11. Kang JH, Cook N, Manson J, Buring JE, Grodstein F A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006, 166:2462-2468.
12. Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 2008, 88:1602-1610.
13. Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, Fezeu L, Hercberg S, Galan P Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr 2011, 94:278-286.
14. Shatenstein B, Kergoat MJ, Reid I Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls. J Am Diet Assoc 2007, 107:2091-2099.
15. Zawia NH, Lahiri DK, Cardozo-Pelaez Epigenetics, oxidative stress and Alzheimer's disease. Free Rad Biol Med 2009, 46:1241-1249.
16. Resende R, Moreira PI, Proença T, Deshpande A, Busciglio J, Pereira C, et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008, 44:2051-2057.
17. Ho PI, Ortiz D, Rogers E, Shea TB Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 2002, 70:694-702.
18. Peters I, Igbavboa U, Schütt T, Haidari S, Hartig U, Rosello X, et al. The interaction of beta-amyloid protein with cellular membranes stimulates its own production. Biochim Biophys Acta 2009, 1788:964-972.
19. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, et al. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 2008, 104:683-695.
20. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, et al. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998, 70:2212-2215.
21. Kamboh MI Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 2004, 68:381-404.
22. Shea TB, Rogers E Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E. Mol Brain Res 2002, 108:1-6.
23. Shea TB, Chan A S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer's disease. J Alzheimers Dis 2008, 13:67-70.
24. Bayer TA, Schäfer S, Breyhan H, Wirths O, Treiber C, Multhaup G A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease. Clin Neuropathol 2006, 25:163-171.
25. Mattson MM, Shea TB Folate and homocysteine in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003, 26:137-146.
26. Shea TB, Rogers E Lifetime requirement of the methionine cycle for neuronal development and maintenance. Curr Opin Psych 2014, [in press].
27. Kennedy BP, Bottiglieri T, Arning E, Zeigler MG, Hansen LA, Masliah E Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J Neural Transm 2004, 111:547-567.
28. Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990, 53:1096-1098.
29. Fuso A, Cavallaro RA, Zampelli A, D'Anselmi F, Piscopo P, Confaloni A, et al. Gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J Alzheimers Dis 2007, 11:275-290.
30. Lee S, Lemere CA, Frost JL, Shea TB Dietary supplementation with S-adenosyl methionine delayed amyloidβ and tau pathology in 3xTg-AD mice. J Alzheimers Dis 2011, [Epub ahead of print].
31. Dhitavat S, Ortiz D, Rogers E, Rivera E, Shea TB Folate, vitamin E and acetyl-l-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid beta. Brain Res 2005, 1061:114-117.
32. Kifle K, Ortiz D, Shea TB Folate and B12 provide superior neuroprotection in combination than does either vitamin alone. J Alzheimers Dis 2009, 16:533-540.
33. Tchantchou F, Graves M, Ortiz D, Shea TB Expression and activity of methionine cycle genes are altered following folate and vitamin E deficiency under oxidative challenge: modulation by apolipoprotein E-deficiency. Nutr Neurosci 2005, 9:17-24.
34. Chan A, Lepore A, Kotoya E, Zemianek J, Remington R, Shea TB Efficacy of a vitamin/nutriceutical formulation on cognitive speed and recall in adults with no known or suspected dementia. J Nutr Health Aging 2010, 14:224-230.
35. Chan A, Paskavitz J, Remington R, Shea TB Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a one-year open-label pilot study with a 16-month extension. Am J Alzheimers Dis Other Demen 2008, 23:571-585.
36. Remington R, Chan A, Shea TB Efficacy of a vitamin/nutriceutical formulation for moderate to late-stage Alzheimer's disease: a placebo-controlled pilot study. Am J Alzheimers Dis Other Demen 2009, 24:27-33.
37. Remington R, Chan A, Lepore A, Kotlya E, Shea TB Apple juice improved behavioral symptoms in moderate- to late-stage Alzheimer's disease in an open-label pilot study. Am J Alzheimers Dis Other Demen 2010, 25:367-371.
38. Connelly PJ, Prentice NP, Cousland G, Bonham J A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychiatry 2008, 23:155-160.
39. Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 2007, 29:2204-2214.
40. Okosun IS, Davis-Smith M, Seale JP Awareness of diabetes risks is associated with healthy lifestyle behavior in diabetes free American adults: evidence from a nationally representative sample. Prim Care Diabetes 2012, [Epub Jan 17].
41. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Alzheimer's Disease Cooperative Study Group, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005, 352:2379-2388.
42. Cornelli U Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants. Neurodegener Dis 2010, 7:193-202.
43. Ballard C, Khan Z, Clack H, Corbett A Nonpharmacological treatment of Alzheimer disease. Can J Psychiatry 2011, 56:589-595.
44. Daviglus ML, Plassman BL, Pirzada A, Bell CC, Bowen PE, Burke JR, et al. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol 2011, 68:1185-1190.
45. Solfrizzi V, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, D'Onofrio G, et al. Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res 2011, 8:520-542.
46. Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G Integrated treatment approach improves cognitive function in demented and clinically depressed patients. Am J Alzheimers Dis Other Demen 2005, 20:21-26.
47. Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?. Br J Clin Pharmacol 2011, 71:365-376.
48. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?. J Alzheimers Dis 2005, 7:63-80.
49. Rogers E Has enhanced folate status during pregnancy altered natural selection and possibly autism prevalence? A closer look at a possible link. J Med Hypoth 2008, 71:406.
50. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002, 22:1752-1762.